Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function

PLoS ONE(2022)10.1371/journal.pone.0275182Source: DataRank Database

Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.36)OA: goldTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Katherine D. Porter ORCID,Pamela M. Quizon ORCID,Sarah E. Davis ORCID,Steven Lin ORCID,Yaxia Yuan ORCID

Live enrichment

PubMed:36170295 PMC:PMC9518868 OpenAlex:https://openalex.org/W4297458275

National Institute on Drug Abuse

Grant: DA035714

National Institute on Drug Abuse

Grant: DA047924

NIDA NIH HHS

Grant: R01 DA047924

NIDA NIH HHS

Grant: R01 DA035714

FWCI

0.36

Citation Percentile

0.6%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0275182&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0275182&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0275182

journalhttps://doi.org/10.1371/journal.pone.0275182

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36170295

Fields of Study

HIV Research and TreatmentHIV/AIDS drug development and treatmentAdvanced biosensing and bioanalysis techniquesAnimalsCricetinaeCricetulusDopamineDopamine Plasma Membrane Transport ProteinsFluoxetineHIV-1HistidineHumansMutationNorepinephrineNorepinephrine Plasma Membrane Transport ProteinsPhenylalanineRatsSymportersTrans-ActivatorsTyrosine

MeSH Terms

AnimalsCricetulusDopamineFluoxetineCricetinaeHistidineHumansMutationNorepinephrinePhenylalanineTyrosineHIV-1Trans-ActivatorsSymportersDopamine Plasma Membrane Transport ProteinsNorepinephrine Plasma Membrane Transport ProteinsRats

Keywords

Dopamine transporterDopamineNorepinephrine transporterReuptakeDopaminergicChemistryWild typeCatecholamineMutantDopamine Plasma Membrane Transport ProteinsBiologyBiochemistryNorepinephrineEndocrinologySerotoninReceptorGene

Sustainable Development Goals

SDG 0: Good health and well-being

Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function

FAIR Checklist

Authors (10)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)